Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Adalberto, Pessoa Junior"'
Autor:
Louise Lacalendola Tundisi, Diego de Freitas Coêlho, Alessandra Valéria de Sousa Faria, Adalberto Pessoa Junior, Elias Basile Tambourgi, Laura de Oliveira Nascimento, Edgar Silveira, Priscila Gava Mazzola
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 58 (2022)
Abstract L-Asparaginase (L-ASNase) is a biopharmaceutical used for acute lymphoblastic leukaemia (ALL) treatment, dramatically increasing the patients’ chance of cure. However, its production and distribution in developing countries were disrupted
Externí odkaz:
https://doaj.org/article/102ccfa4a5024dcd80c6e5ae31d7466a
Autor:
Marcela Freitas, Paula Souza, Mauricio Homem-de-Mello, Yris M. Fonseca-Bazzo, Damaris Silveira, Edivaldo X. Ferreira Filho, Adalberto Pessoa Junior, Dipak Sarker, David Timson, João Inácio, Pérola O. Magalhães
Publikováno v:
Pharmaceuticals, Vol 15, Iss 6, p 746 (2022)
L-asparaginase is an important enzyme in the pharmaceutical field used as treatment for acute lymphoblastic leukemia due to its ability to hydrolyze L-asparagine, an essential amino acid synthesized by normal cells, but not by neoplastic cells. Adver
Externí odkaz:
https://doaj.org/article/816ee450df474fa1a5fe9db259dd5a1e
Autor:
Daniela Camargo Furuya, Silgia Aparecida da Costa, Rodrigo Cardoso de Oliveira, Humberto Gomes Ferraz, Adalberto Pessoa Junior, Sirlene Maria da Costa
Publikováno v:
Materials Research, Vol 20, Iss 2, Pp 377-386 (2017)
The main aim of this study was to develop scaffolds based on alginate, chitosan and hybrid fibers with and without glycerol. The scaffolds developed underwent assessments for tensile property, swelling ratio and weight loss, cellular viability, degra
Externí odkaz:
https://doaj.org/article/88394869f1d84949a5d408df276a5c11
Autor:
Giovanna Pastore Meneguetti, João Henrique Picado Madalena Santos, Karin Mariana Torres Obreque, Christiano Marcello Vaz Barbosa, Gisele Monteiro, Sandra Helena Poliselli Farsky, Adriano Marim de Oliveira, Claudia Blanes Angeli, Giuseppe Palmisano, Sónia Patrícia Marques Ventura, Adalberto Pessoa-Junior, Carlota de Oliveira Rangel-Yagui
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0224592 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0211951.].
Externí odkaz:
https://doaj.org/article/ec9d5b86d4e147158c0721c52d46a70b
Autor:
Giovanna Pastore Meneguetti, João Henrique Picado Madalena Santos, Karin Mariana Torres Obreque, Christiano Marcello Vaz Barbosa, Gisele Monteiro, Sandra Helena Poliselli Farsky, Adriano Marim de Oliveira, Claudia Blanes Angeli, Giuseppe Palmisano, Sónia Patrícia Marques Ventura, Adalberto Pessoa-Junior, Carlota de Oliveira Rangel-Yagui
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211951 (2019)
L-asparaginase (ASNase) from Escherichia coli is currently used in some countries in its PEGylated form (ONCASPAR, pegaspargase) to treat acute lymphoblastic leukemia (ALL). PEGylation refers to the covalent attachment of poly(ethylene) glycol to the
Externí odkaz:
https://doaj.org/article/5db8af36663d44a9ae74798958813f0c
Autor:
Larissa Pereira Brumano, Francisco Vitor Santos da Silva, Tales Alexandre Costa-Silva, Alexsandra Conceição Apolinário, João Henrique Picado Madalena Santos, Eduardo Krebs Kleingesinds, Gisele Monteiro, Carlota de Oliveira Rangel-Yagui, Brahim Benyahia, Adalberto Pessoa Junior
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 6 (2019)
L-Asparaginase (ASNase) is a vital component of the first line treatment of acute lymphoblastic leukemia (ALL), an aggressive type of blood cancer expected to afflict over 53,000 people worldwide by 2020. More recently, ASNase has also been shown to
Externí odkaz:
https://doaj.org/article/3b42ba4ad6e14b53b58583ec4ea24b82
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Autor:
Marcela, Freitas, Paula, Souza, Mauricio, Homem-de-Mello, Yris M, Fonseca-Bazzo, Damaris, Silveira, Edivaldo X, Ferreira Filho, Adalberto, Pessoa Junior, Dipak, Sarker, David, Timson, João, Inácio, Pérola O, Magalhães
Publikováno v:
Pharmaceuticals (Basel, Switzerland). 15(6)
L-asparaginase is an important enzyme in the pharmaceutical field used as treatment for acute lymphoblastic leukemia due to its ability to hydrolyze L-asparagine, an essential amino acid synthesized by normal cells, but not by neoplastic cells. Adver
Autor:
Kellen Cruvinel Rodrigues Andrade, Marcela de Freitas Medeiros, Paula Monteiro de Souza, Thaís de Souza Barros, Samuel Leite Cardoso, Adalberto Pessoa Junior, Edivaldo Ximenes Ferreira Filho, Pérola de Oliveira Magalhães Dias Batista
Publikováno v:
Brazilian Journal of Health Review.
L-asparaginase é uma enzima importante no setor farmacêutico utilizada no tratamento para a leucemia linfoblástica aguda (LLA) devido à sua capacidade de hidrolisar a L-asparagina em L-aspartato e amônia (Gurunathan e Sahadevan, 2012; Nomme et a
Publikováno v:
Polymers, Vol 3, Iss 1, Pp 587-601 (2011)
Aqueous two-phase systems consisting of polyethylene glycol (PEG), sodium polyacrylate (NaPAA), and a salt have been studied. The effects of the polymer size, salt type (NaCl, Na2SO4, sodium adipate and sodium azelate) and salt concentrations on the
Externí odkaz:
https://doaj.org/article/c4a75e988a1647709096a6fbb5b4d1a4